$0.56-0.00|(-0.28%)
52W H: 2.3552W L: 0.532Beta: 2.87

About Tenaya Therapeutics Inc

Frequently Asked Questions

What is the 52-week range for TNYA?

The 52-week high is $2.35 and the 52-week low is $0.532.

What is the P/E ratio for TNYA?

The P/E ratio data is currently unavailable.

What is the dividend yield for TNYA?

This company does not currently pay a dividend or the data is unavailable.

What is the Return on Equity (ROE)?

The trailing twelve months (TTM) Return on Equity is -108.05%.

What is the Net Profit Margin?

Net Margin data is currently unavailable.

What is the Price to Book (P/B) Ratio?

The annual Price to Book ratio stands at 1.25.

Analyst Recommendation Trends

Wall Street analyst consensus for TNYA over the last few months:

2026-09-01
Buy: 8
S.Buy: 4
Hold: 1
Sell: 0
2026-08-01
Buy: 8
S.Buy: 4
Hold: 1
Sell: 0
2026-07-01
Buy: 9
S.Buy: 4
Hold: 1
Sell: 0
2026-06-01
Buy: 9
S.Buy: 4
Hold: 1
Sell: 0

Latest TNYA News

Tenaya Therapeutics, Inc. (TNYA) Presents at H.C. Wainwright 28th Annual Global Investment Conference Transcript

Tenaya Therapeutics, Inc. (TNYA) H.C.

SeekingAlpha9/17/2026

Tenaya Therapeutics Granted U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for TN-401 for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy

RMAT Designation Supported by Positive Interim Data from RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 which Demonstrated Reduced Arrhythmia Burden Additional Data and Updates on Regulatory Discussions Anticipated in 4Q 2026 SOUTH SAN FRANCISCO, Calif., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease,

Yahoo9/14/2026

FDA Grants Regenerative Medicine Advanced Therapy Designation To Tenaya Therapeutics’ TN-401, Gene Therapy Candidate For Treatment Of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy

RMAT Designation Supported by Positive Interim Data from RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 which Demonstrated Reduced Arrhythmia Burden Additional Data and Updates on Regulatory Discussions Anticipated in 4Q

Benzinga9/14/2026

Treasury yields rise as investors raise bets on Fed rate hike: AlphaCheck

Stocks were down on Thursday as investors watched for stress signs in the bond market as long dated bond yields as oil prices remain elevated .

Yahoo9/10/2026

Related Stocks (Peers)

Companies operating in similar sectors to TNYA:

Recent Insider Transactions

DateNameShares ChangedPriceValue
2026-09-10Tingley Whittemore+293,000--
2026-09-10Tingley Whittemore+49,000--
2026-09-10Ali Faraz+732,500--
2026-09-10Ali Faraz+122,000--
2026-08-17Tingley Whittemore-2,279$0.7098$1,618
2026-08-17Tingley Whittemore-1,871$0.7098$1,328
2026-08-17Tingley Whittemore-1,637$0.7098$1,162
2026-08-17Tingley Whittemore-1,637$0.7098$1,162
2026-08-17Ali Faraz-7,406$0.7097$5,256
2026-08-17Ali Faraz-5,020$0.7097$3,563
2026-08-17Ali Faraz-3,969$0.7098$2,817
2026-08-17Ali Faraz-5,837$0.7097$4,143
2026-07-13Hyllengren Eric J+1,650,000--
2026-05-28Srivastava Deepak+120,000--
2026-05-28Burroughs Amy L.+120,000--
2026-05-28Stehman-Breen Catherine+120,000--
2026-05-28Lee June+120,000--
2026-05-28Parschauer Karah Herdman+120,000--
2026-05-28Walsh Jeffrey T.+120,000--
2026-05-28Williams R Sanders+120,000--
2026-05-18Tingley Whittemore-3,121$0.7936$2,477
2026-05-18Higa Tomohiro-1,485$0.7932$1,178
2026-05-18Ali Faraz-3,390$0.7934$2,690
2026-02-25Svennilson Peter-1,862,545$0.5624$1,047,495
2026-02-25Svennilson Peter-1,649,281$0.5624$927,556
2026-02-24Svennilson Peter-349,212$0.6153$214,870
2026-02-24Svennilson Peter-309,228$0.6153$190,268
2026-02-23Svennilson Peter-162,291$0.5972$96,920
2026-02-23Svennilson Peter-143,709$0.5972$85,823
2026-02-20Svennilson Peter-277,769$0.6149$170,800
2026-02-20Svennilson Peter-245,965$0.6149$151,244
2026-02-17Higa Tomohiro-2,022$0.6431$1,300
2026-02-17Higa Tomohiro-836$0.6434$538
2026-02-17Higa Tomohiro-611$0.6434$393
2026-02-17Tingley Whittemore-1,876$0.6431$1,206
2026-02-17Tingley Whittemore-1,642$0.6432$1,056
2026-02-17Tingley Whittemore-1,642$0.6432$1,056
2026-02-17Ali Faraz-5,032$0.643$3,236
2026-02-17Ali Faraz-3,979$0.6431$2,559
2026-02-17Ali Faraz-5,851$0.643$3,762
2026-02-11Svennilson Peter-2,151,458$0.6808$1,464,713
2026-02-11Svennilson Peter-1,905,115$0.6808$1,297,002
2026-02-10Svennilson Peter-182,295$0.8161$148,771
2026-02-10Svennilson Peter-161,422$0.8161$131,736
2026-02-03Higa Tomohiro+175,500--
2026-02-03Higa Tomohiro+29,250--
2026-02-03Tingley Whittemore+318,500--
2026-02-03Tingley Whittemore+48,750--
2026-02-03Ali Faraz+952,250--
2026-02-03Ali Faraz+158,600--
2025-11-17Higa Tomohiro-1,367$1.33$1,818
2025-11-17Tingley Whittemore-2,877$1.33$3,826
2025-11-17Ali Faraz-3,126$1.33$4,158